Date published: 2026-4-25

1-800-457-3801

SCBT Portrait Logo
Seach Input

Mms2 Inhibitors

Mms2 inhibitors represent a class of chemical compounds designed to specifically interfere with the function of Mms2, also known as Ubc13. Mms2 is an integral component of the ubiquitin-conjugating enzyme (E2) system, a fundamental cellular mechanism responsible for orchestrating protein degradation and DNA repair pathways. In the context of Mms2 inhibitors, their primary objective is to disrupt the enzymatic activity of Mms2, thus affecting the synthesis of K63-linked polyubiquitin chains, a crucial post-translational modification pivotal for regulating various cellular processes. These processes encompass DNA damage response, intracellular signaling cascades, and protein trafficking among others. Typically, Mms2 inhibitors achieve their mechanism of action by targeting the active site or the binding interface of Mms2, thereby inhibiting its interaction with the ubiquitin-conjugating enzyme Uev1a (also known as Ube2V1).

This interaction between Mms2 and Uev1a is indispensable for the transfer of ubiquitin moieties to specific target substrates, culminating in the formation of K63-linked polyubiquitin chains. The disruption of this interaction through Mms2 inhibitors consequently obstructs the synthesis of these specific polyubiquitin chains, which serve as vital molecular signals in DNA repair and other critical cellular processes. As a result, inhibition of Mms2 leads to the accumulation of unrepaired DNA lesions, perturbed cell signaling, and potentially activation of cell cycle arrest or apoptosis pathways, contingent upon the degree of DNA damage. Mms2 inhibitors are invaluable research tools, enabling scientists to explore the role of K63-linked polyubiquitin chains in diverse cellular contexts and to gain insights into the fundamental biology of ubiquitination. Through their use, researchers are able to dissect intricate protein-protein interactions and elucidate signal transduction pathways, thereby shedding light on the broader implications of this ubiquitin modification in various cellular contexts.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

MLN 4924

905579-51-3sc-484814
1 mg
$286.00
1
(0)

MLN4924 inhibits the NEDD8-activating enzyme (NAE), preventing the neddylation of cullin-RING ligases (CRLs). This inhibits the ubiquitin-proteasome pathway, leading to the accumulation of various proteins involved in cell cycle regulation and DNA repair, ultimately inducing apoptosis.

NSC697923

343351-67-7sc-391107
sc-391107A
1 mg
5 mg
$15.00
$52.00
3
(1)

NSC697923 is a small molecule inhibitor that disrupts the assembly of the CRL complex by targeting the NEDD8-activating enzyme. By inhibiting CRL-mediated ubiquitination, it stabilizes key proteins involved in cell cycle control and DNA repair, leading to cell cycle arrest and apoptosis.

MLN7243

1450833-55-2sc-507338
5 mg
$340.00
(0)

TAK-243 is a selective inhibitor of the NEDD8-activating enzyme (NAE). It disrupts the neddylation of cullin-RING ligases (CRLs), which results in the accumulation of CRL substrates, leading to cell cycle arrest and apoptosis.